Fecal occult blood test: a valuable aid in the early diagnosis of colorectal cancer
Keywords:
Colorectal neoplasms/diagnosis, Occult blood, Feces.Abstract
Introduction: colorectal cancer has increased in recent years; the clinical laboratory diagnostic elements can provide simple and specific features when it is still asymptomatic with great healing potential.
Objectives: to determine the relationship between the study of occult blood, positive blood stool and related diseases at Turcios Lima Teaching Polyclinic in Pinar del Río.
Method: a descriptive, cross-sectional study was conducted in order to diagnose and detect fecal occult blood in patients belonging to the health area of Pinar del Río, between July 2014 to June 2015; 35 patients comprised the target group they attended to the fecal laboratory studies, they were randomly selected and the sample included 410 patients who met the pre-established criteria.
Results: out of the 410 cases included, only 10% were positive for the procedure, 22 men and 18 women; ages from 40-50 prevailed and ages from 50-60 years. Eight (8) patients agreed not to continue the study, 32 were underwent colonoscopy and the results were suggestive of gastrointestinal malignancies.
Conclusions: a high incidence was found among positive fecal occult blood and the expression of colorectal cancer, male patients in productive ages of life (40-50 years) predominated, it is recommended a more extensive use of this diagnostic means to the entire population since it has simple risk, it is economical and safe; these screening tests are applicable at all levels of care.Downloads
References
1. Rodríguez Fernández Z, Jean-Louis B, Lozada Prado GA, Joubert Álvarez G, Pineda Chacón J. Conocimientos vigentes acerca del cáncer de colon recurrente. MEDISAN [Internet]. 2015 Jun [citado 2016 Jun 14]; 19(6): [Aprox. 17 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000600013&lng=es
2. Ibáñez Sanz G, García M, Rodríguez Moranta F, Gómez Matas J, Binefa G, Padrol I, et al. Falsos negativos del cribado de cáncer colorrectal mediante test de sangre oculta en heces y colonoscopia como prueba diagnóstica. Endoscopy. [Internet]. 2015 [citado 2016 Jun 14]; 47(13): [Aprox. 17 p.]. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1566034
3. Menéndez P, Villarejo P, Padilla D, Menéndez JM, Rodríguez Montes A. Epigenética y cáncer colorrectal. Cirugía Española. [Internet]. 2012 [citado 2016 Jun 14]; 90(5): [Aprox. 12 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0009739X11004350
4. López FK. Actualización en el diagnóstico y tratamiento quirúrgico de los pacientes con cáncer colo rectal. Revista Médica Clínica Las Condes. [Internet]. 2013 [citado 2016 Jun 14]; 24(4): [Aprox. 16 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0716864013702037
5. Domènech X, García M, Benito L, Binefa G, Vidal C, et al. Cánceres de intervalo y sensibilidad de los programas poblacionales de cribado de cáncer colorrectal. Gaceta Sanitaria. [Internet]. 2015 [citado 2016 Jun 14]; 29(6): [Aprox. 14 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213911115001442
6. Comparación de dos métodos utilizados para la detección del cáncer colorrectal. The Cochrane Collaboration: Colorectal Cancer Group [Internet]. © 2016 [Actualizado 9 dic 2013; citado 14 jun 2016]. [Aprox. 5 p.]. Disponible en: http://www.cochrane.org/es/CD009259/comparacion-de-dos-metodos-utilizados-para-la-deteccion-del-cancer-colorrectal
7. Carballo F, Muñoz-Navas M. Prevenir o curar en época de crisis: a propósito del cribado de cáncer de colon y recto. Rev. esp. enferm. dig. [Internet]. 2012 Nov [citado 2016 Jun 14]; 104(1): [Aprox. 16 p.]. Disponible en: http://pesquisa.bvsalud.org/ses/resource/pt/ibc-107992. http://dx.doi.org/10.4321/S1130-01082012001000006
8. Del Valle Llufrio P, Romero Bareiro SR, Santana Fuentes Y. Lesiones de colon diagnosticadas por colonoscopia en pacientes con sangre oculta positiva. Rev. Med. Electron. [Internet]. 2014 [citado 2016 Jun 14]; 36(Suppl 1): [Aprox. 14 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242014000700002&lng=es
9. Portillo I, Idígoras I, Ojembarrena E, Arana-Arri E, Begoña Zubero M, Pijoán JI, et al. Principales resultados del programa de cribado de cáncer colorrectal en el País Vasco. Gaceta Sanitaria. [Internet]. 2013 [citado 2016 Jun 14]; 27(4): [Aprox. 14 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213911113000058
10. Hernández Betancourt JC, Camejo Nieves ME, Rodríguez Alonso M, Morales Rodríguez L, Rodríguez Rosales M. Ensayo de sangre oculta en heces fecales en pacientes del hospital “Ernesto Guevara”. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. [Internet]. 2016 [citado 2016 Jun 14]; 41(4): [Aprox. 14 p.]. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/viewFile/680/pdf_265
11. Hano García OM, Castellanos Gutiérrez M, Calzadilla Bertot L, Villa Jiménez O Ml. Validación de técnica inmunoquímica para detección de sangre oculta en heces. Rev Cubana Invest Bioméd [Internet]. 2014 Mar [citado 2016 Jun 14]; 33(1): [Aprox. 28 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002014000100003&lng=es
12. Lage Dávila A, Crombet Ramos T. Del nuevo producto biológico para el cáncer al impacto en la salud poblacional. Rev. cub. salud pública [Internet]. 2012 Jan [cited 2016 June 14]; 38(Suppl 5): [Aprox. 24 p.]. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0864-34662012000500011&lng=en
13. Montalvo Torres MA. Detección temprana del Cáncer Colorrectal mediante la estrategia de tamizaje protocolizada en personas entre los 50 y 75 años de edad asintomáticos en el área de influencia del Hospital “Pablo Arturo Suárez”. 2014. [Tesis en Internet]. Ecuador: Universidad San Francisco De Quito; © 2014 [citado 14 jun 2016]. [Aprox. 54 p.]. Disponible en:
http://repositorio.usfq.edu.ec/bitstream/23000/3439/1/111052.pdf
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
